Genetics and epigenetics

New collaborative guidelines for molecular biomarker testing in colorectal cancer

Two experts explain why they believe ctDNA analysis is the future of cancer pathology

George Calin, Professor, Department of Experimental Therapeutics, and Co-Director, The Center for RNA Interference and Non-coding RNAs, MD Anderson Cancer Center, USA

To win the war on cancer, we need to put proteomics on an equal footing with genomics

New biomarkers could predict cognitive decline in Parkinson's disease patients

Ultrasensitive mutation analysis could boost the potential of liquid biopsy

A genome-wide study shows that anorexia isn't purely psychiatric: metabolic factors also play a role

A test to profile intestinal microbiota could help diagnose inflammatory bowel disease

Can genetic home test kits ever be a good thing?

Protocols that allow multiple simultaneous -omic studies are the way of the future